Rhythm Biosciences Ltd has released a press release.
Rights Issue Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
In the deck
Earlier from Rhythm Biosciences
- Non renouneable rights issue prospectus
- Rhythm Establishes US Entity To Drive US Expansion Strategy
- Rhythm to Present at MST Access Investor Conference
- RHY adds Sonic Clinical Services to ColoSTAT Clinical Trial
- FY22 Strategic Update
Later from Rhythm Biosciences
- Non Renounceable pro rata offer - Completion of despatch
- Initial TGA Regulatory Documentation Submitted
- Rhythm Completes Strongly Oversubscribed $4.3M Rights Issue
- TGA Accepts Initial Regulatory Documentation
- Rhythm Completes Recruitment for Clinical Trial (Study 7)
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences